These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9545813)

  • 1. [Is the ABVD an optimal regimen for Hodgkins disease?].
    Nakamura S
    Rinsho Ketsueki; 1998 Feb; 39(2):109-10. PubMed ID: 9545813
    [No Abstract]   [Full Text] [Related]  

  • 2. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
    J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABVD associated with imatinib for coexisting chronic myeloid leukaemia and relapsed Hodgkin lymphoma.
    Ferrario A; Radaelli F; Goldaniga M; F FG; Olivero B; Rossi F; Baldini L
    Leuk Res; 2010 Oct; 34(10):e280-1. PubMed ID: 20605208
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
    Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
    Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hodgkin lymphoma--ABVD regimen].
    Nagai H
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():642-5. PubMed ID: 25831839
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous flagellate pigmentation by bleomycin.
    Spedini P; Bergonzi C; Morandi S
    Haematologica; 2000 Aug; 85(8):870. PubMed ID: 10942936
    [No Abstract]   [Full Text] [Related]  

  • 7. [Five-year outcome of a new combination chemotherapy with CEA/ABVD for advanced Hodgkin's disease with poor prognosis].
    Kharchenko VP; Datsenko PV; Panyshin GA; Sotnikov VM; Mel'nik IuD
    Vopr Onkol; 2006; 52(5):531-7. PubMed ID: 17168361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired Glanzmann thrombasthenia associated with Hodgkin lymphoma: rapid reversal of functional platelet defect with ABVD (adriamycin/bleomycin/vinblastine/dacarbazine) chemotherapy.
    Raman V; Quillen K; Sloan JM
    Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):e51-4. PubMed ID: 24342105
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of outcomes in studies of advanced Hodgkin's lymphoma.
    Johnson PW; Radford JA; Cullen MH; Sydes MR; Stenning SP; Hancock BW
    J Clin Oncol; 2006 Jul; 24(20):3309; author reply 3309-10. PubMed ID: 16829655
    [No Abstract]   [Full Text] [Related]  

  • 11. Hairy cell leukemia responsive to chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD).
    Patten E; Gill DP; Weiss GB
    Cancer Treat Rep; 1983 Dec; 67(12):1147-8. PubMed ID: 6197166
    [No Abstract]   [Full Text] [Related]  

  • 12. Uncommon presentations of Hodgkin's disease. Case 3. Hodgkin's disease: rectal presentation.
    Simpson L; Taylor S; Piotrowski A
    J Clin Oncol; 2004 Jan; 22(1):196-8. PubMed ID: 14701784
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphoma.
    Younes A; Fayad L; Romaguera J; Pro B; Goy A; Wang M
    Eur J Cancer; 2006 Nov; 42(17):2976-81. PubMed ID: 17008093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consolidation radiotherapy may improve outcomes in people with Hodgkin's disease achieving complete remission after combination chemotherapy.
    Specht L
    Cancer Treat Rev; 2004 Aug; 30(5):479-82. PubMed ID: 15245780
    [No Abstract]   [Full Text] [Related]  

  • 15. The vanishing bile duct syndrome in a child with Hodgkin disease.
    Ozkan A; Yoruk A; Celkan T; Apak H; Yildiz I; Ozbay G
    Med Pediatr Oncol; 2001 Mar; 36(3):398-9. PubMed ID: 11241447
    [No Abstract]   [Full Text] [Related]  

  • 16. [The whole dose at once?].
    Rodríguez García J; Ramos Ortega FJ; Sandoval Guerra V; García Sanz R
    Sangre (Barc); 1996 Jun; 41(3):259. PubMed ID: 8755216
    [No Abstract]   [Full Text] [Related]  

  • 17. A case with Hodgkin lymphoma and fronto-temporal lobular degeneration (FTLD)-like dementia facilitated by chemotherapy.
    Katsumata R; Sagawa R; Akechi T; Shinagawa Y; Nakaaki S; Inagaki A; Okuyama T; Akazawa T; Furukawa TA
    Jpn J Clin Oncol; 2010 Apr; 40(4):365-8. PubMed ID: 20026458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of standard treatment in patients with Hodgkin's disease--a single center experience.
    Geissler K; Gisslinger H; Knöbl P; Sperr W; Valent P; Dieckmann K; Chott A; Pötter R; Lechner K; Jäger U
    Wien Klin Wochenschr; 2000 Jul; 112(14):624-8. PubMed ID: 11008324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma: reply to D'Arco et al.
    Pinto A; Corazzelli G
    Br J Haematol; 2015 Nov; 171(4):665-8. PubMed ID: 25892204
    [No Abstract]   [Full Text] [Related]  

  • 20. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
    Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
    Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.